Evome Medical Technologies Inc.
LNDZF · OTC
12/31/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Market Cap | $14,746 | $24,323 | $7,111 | $5,420 |
| - Cash | $919 | $8,057 | $7,081 | $8,349 |
| + Debt | $24,690 | $10,533 | $0 | $0 |
| Enterprise Value | $38,518 | $26,799 | $30 | -$2,930 |
| Revenue | $62,627 | $18,312 | -$34 | $352 |
| % Growth | 242% | 54,686.9% | -109.5% | – |
| Gross Profit | $22,533 | $5,962 | -$12,384 | -$20 |
| % Margin | 36% | 32.6% | 36,914.6% | -5.8% |
| EBITDA | -$10,421 | -$3,244 | -$1,438 | -$1,634 |
| % Margin | -16.6% | -17.7% | 4,285.3% | -464.1% |
| Net Income | -$15,603 | -$4,372 | -$2,667 | -$2,341 |
| % Margin | -24.9% | -23.9% | 7,951.3% | -664.9% |
| EPS Diluted | -0.16 | -0.1 | -0.061 | -0.069 |
| % Growth | -60.3% | -63.7% | 11.8% | – |
| Operating Cash Flow | -$919 | -$3,704 | -$975 | -$128 |
| Capital Expenditures | -$203 | -$55 | -$55 | $0 |
| Free Cash Flow | -$1,122 | -$3,759 | -$1,030 | -$128 |